Structural basis for norovirus inhibition and fucose mimicry by citrate

Journal of Virology

Volumn 86, Issue 1, 2012, Pages 284-292

  Hansman, Grant S ^a,b   Shahzad ul Hussan, Syed ^a,c   McLellan, Jason S ^a   Chuang, Gwo Yu ^a   Georgiev, Ivelin ^a   Shimoike, Takashi ^b   Katayama, Kazuhiko ^b   Bewley, Carole A ^c   Kwong, Peter D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; CITRIC ACID; FUCOSE; PYRANOSIDE; TRISACCHARIDE;

ANTIBODY COMBINING SITE; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; NONHUMAN; NOROVIRUS; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURE ANALYSIS; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS INHIBITION; X RAY CRYSTALLOGRAPHY;

BINDING SITES; BLOOD GROUP ANTIGENS; CAPSID PROTEINS; CITRIC ACID; CRYSTALLOGRAPHY, X-RAY; DOWN-REGULATION; FUCOSE; GASTROENTERITIS; HUMANS; KINETICS; MODELS, MOLECULAR; NOROVIRUS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

MIRIDAE; NOROVIRUS;

EID: 84855934642     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05909-11     Document Type: Article

References (55)

1. Adams PD, et al. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66:213-221.
2. Angulo J, Enriquez-Navas PM, Nieto PM. 2010. Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates. Chemistry 16:7803-7812.
3. Ausar SF, Foubert TR, Hudson MH, Vedvick TS, Middaugh CR. 2006. Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature. J. Biol. Chem. 281:19478-19488.
4. Berman HM, et al. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-242.
5. Bianchet MA, Odom EW, Vasta GR, Amzel LM. 2002. A novel fucose recognition fold involved in innate immunity. Nat. Struct. Biol. 9:628-634.
6. Bok K, et al. 2009. Evolutionary dynamics of GII. 4 noroviruses over a 34-year period. J. Virol. 83:11890-11901.
7. Boraston AB, Wang D, Burke RD. 2006. Blood group antigen recognition by a Streptococcus pneumoniae virulence factor. J. Biol. Chem. 281: 35263-35271.
8. Bu W, et al. 2008. Structural basis for the receptor binding specificity of Norwalk virus. J. Virol. 82:5340-5347.
9. Bull RA, Tu ET, McIver CJ, Rawlinson WD, White PA. 2006. Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis. J. Clin. Microbiol. 44:327-333.
10. Bull RA, White PA. 2011. Mechanisms of GII.4 norovirus evolution. Trends Microbiol. 19:233-240.
11. Cao S, et al. 2007. Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 81:5949-5957.
12. Choi JM, Hutson AM, Estes MK, Prasad BV. 2008. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc. Natl. Acad. Sci. U. S. A. 105:9175-9180.
13. Collaborative Computational Project N. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D. Biol. Crystallogr. 50:760-763.
14. De Jong JC, Rimmelzwaan GF, Fouchier RA, Osterhaus AD. 2000. Influenza virus: a master of metamorphosis. J. Infect. 40:218-228.
15. de Rougemont A, et al. 2011. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J. Virol. 85:4057-4070.
16. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66:486-501.
17. Fang M, Agha S, Lee R, Culpepper-Morgan J, D'Souza A. 2000. Perforation of jejunal diverticulum: case report and review of literature. Conn. Med. 64:7-10.
18. Feng X, Jiang X. 2006. Library screen for inhibitors targeting norovirus binding to their histo-blood group antigen receptors. Antimicrob. Agents Chemother. 51:324-331.
19. Fujihashi M, Peapus DH, Kamiya N, Nagata Y, Miki K. 2003. Crystal structure of fucose-specific lectin from Aleuria aurantia binding ligands at three of its five sugar recognition sites. Biochemistry 42:11093-11099.
20. Guardado-Calvo P, et al. 2010. Crystallographic structure of porcine adenovirus type 4 fiber head and galectin domains. J. Virol. 84: 10558-10568.
21. Hansman GS, et al. 2011. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J. Virol. 85:6687-6701.
22. Hansman GS, et al. 2004. Detection of norovirus and sapovirus infection among children with gastroenteritis in Ho Chi Minh City, Vietnam. Arch. Virol. 149:1673-1688.
23. Horm KM, D'Souza DH. 2011. Survival of human norovirus surrogates in milk, orange, and pomegranate juice, and juice blends at refrigeration (4 degrees C). Food Microbiol. 28:1054-1061.
24. Huey R, Morris GM, Olson AJ, Goodsell DS. 2007. A semiempirical free energy force field with charge-based desolvation. J. Comput. Chem. 28: 1145-1152.
25. Jiang X, Wang M, Graham DY, Estes MK. 1992. Expression, selfassembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66:6527-6532.
26. Kageyama T, et al. 2004. Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to norovirus in Japan. J. Clin. Microbiol. 42:2988-2995.
27. Kapikian AZ, et al. 1972. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J. Virol. 10:1075-1081.
28. Kiessling LL, Young T, Gruber TD, Mortell KH. 2008. Glycoscience 12. 4:2483-2523.
29. Levin SA, Dushoff J, Plotkin JB. 2004. Evolution and persistence of influenza A and other diseases. Math. Biosci. 188:17-28.
30. Lindesmith LC, Donaldson EF, Baric RS. 2011. Norovirus GII.4 strain antigenic variation. J. Virol. 85:231-242.
31. Lindesmith LC, et al. 2008. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 5:e31.
32. Marionneau S, et al. 2001. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83:565-573.
33. Marotte K, et al. 2007. X-ray structures and thermodynamics of the interaction of PA-IIL from Pseudomonas aeruginosa with disaccharide derivatives. Chem. Med. Chem. 2:1328-1338.
34. Mayer M, Meyer B. 2001. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123:6108-6117.
35. McCoy AJ, et al. 2007. Phaser crystallographic software. J. Appl. Crystallogr. 40:658-674.
36. Meinecke R, Meyer B. 2001. Determination of the binding specificity of an integral membrane protein by saturation transfer difference NMR: RGD peptide ligands binding to integrin alphaIIbbeta3. J. Med. Chem. 44:3059-3065.
37. Meyer B, Peters T. 2003.NMRspectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem. Int. ed. Engl. 42:864-890.
38. Mitchell EP, et al. 2005. High affinity fucose binding of Pseudomonas aeruginosa lectin PA-IIL: 1.0 A resolution crystal structure of the complex combined with thermodynamics and computational chemistry approaches. Proteins 58:735-746.
39. Morris GM, et al. 1998. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 19:1639-1662.
40. Neffe AT, Bilang M, Meyer B. 2006. Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking. Org. Biomol. Chem. 4:3259-3267.
41. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
42. Penniston KL, Nakada SY, Holmes RP, Assimos DG. 2008. Quantitative assessment of citric acid in lemon juice, lime juice, and commerciallyavailable fruit juice products. J. Endourol. 22:567-570.
43. Prasad BV, et al. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science 286:287-290.
44. Rademacher C, et al. 2011. Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments. Chemistry 17: 7442-7453.
45. Rademacher C, Krishna NR, Palcic M, Parra F, Peters T. 2008. NMR experiments reveal the molecular basis of receptor recognition by a calicivirus. J. Am. Chem. Soc. 130:3669-3675.
46. Shoichet BK. 2004. Virtual screening of chemical libraries. Nature 432: 862-865.
47. Siebenga JJ, et al. 2010. Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog. 6:e1000884.
48. Su X, Howell AB, D'Souza DH. 2010. Antiviral effects of cranberry juice and cranberry proanthocyanidins on foodborne viral surrogates-a time dependence study in vitro. Food Microbiol. 27:985-991.
49. Su X, Howell AB, D'Souza DH. 2010. The effect of cranberry juice and cranberry proanthocyanidins on the infectivity of human enteric viral surrogates. Food Microbiol. 27:535-540.
50. Su X, Sangster MY, D'Souza DH. 2010. In vitro effects of pomegranate juice and pomegranate polyphenols on foodborne viral surrogates. Foodborne Pathog. Dis. 7:1473-1479.
51. Tan M, Hegde RS, Jiang X. 2004. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J. Virol. 78:6233-6242.
52. Tan M, et al. 2009. Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One 4:e5058.
53. Whitehead K, McCue KA. 2010. Virucidal efficacy of disinfectant actives against feline calicivirus, a surrogate for norovirus, in a short contact time. Am. J. Infect. Control. 38:26-30.
54. Yuan P, et al. 2005. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 13:803-815.
55. Zheng DP, et al. 2006. Norovirus classification and proposed strain nomenclature. Virology 346:312-323.